Policy | September 14, 2023
Cabinet approves foreign investment of up to Rs. 9,589 crore in Suven Pharmaceuticals
The approval is for acquisition of up to 76.1% equity shares of Suven Pharmaceuticals by Berhyanda Limited
The approval is for acquisition of up to 76.1% equity shares of Suven Pharmaceuticals by Berhyanda Limited
The Leaders of G20 met in New Delhi and committed to strengthening global health and implementing one health approach
This exposé embarks on an illuminative journey, unfurling the crucial stratagems imperative for upholding public health, achieved through the unyielding fortress of pharmaceutical quality safeguards
The company is committed to address the observations and will submit its response to US FDA within the stipulated time
Reiterates India’s commitment to the BRICS TB Research Network Initiative
Qualifyze specializes in Good Practice audits (GxP) audits and covers a wide range of areas, including excipients, starting materials, packaging, sustainability
More than 9600 Pradhan Mantri Bhartiya Janaushadhi Kendras have been set up covering all districts of the country to promote generic medicines at affordable prices
There is a pressing need for continuous improvement and innovation in food safety systems to keep pace with emerging food trends and habits
The detailed terms in relation to the Rights Issue, including but not limited to the issue price, rights entitlement ratio, record date, timing and terms of payment will be determined in due course.
Exothera will manufacture Meissa’s MV-012-968 vaccine candidate under CGMP regulations to supply Phase 2 clinical trials
Subscribe To Our Newsletter & Stay Updated
